MUSIANI, Piero
 Distribuzione geografica
Continente #
NA - Nord America 6.381
EU - Europa 6.134
AS - Asia 2.816
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 10
SA - Sud America 4
AF - Africa 2
Totale 15.366
Nazione #
US - Stati Uniti d'America 6.326
UA - Ucraina 1.444
CN - Cina 1.373
IE - Irlanda 1.030
TR - Turchia 1.023
GB - Regno Unito 980
SE - Svezia 757
FR - Francia 640
DE - Germania 452
IT - Italia 309
FI - Finlandia 270
IN - India 223
RU - Federazione Russa 161
SG - Singapore 142
CA - Canada 46
CZ - Repubblica Ceca 30
BE - Belgio 28
VN - Vietnam 27
EU - Europa 19
GR - Grecia 18
IL - Israele 14
MX - Messico 8
AU - Australia 6
IR - Iran 6
ES - Italia 5
HK - Hong Kong 4
NZ - Nuova Zelanda 4
PK - Pakistan 3
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
AT - Austria 1
BG - Bulgaria 1
CL - Cile 1
EG - Egitto 1
HU - Ungheria 1
JP - Giappone 1
NL - Olanda 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
Totale 15.366
Città #
Jacksonville 1.443
Chandler 1.249
Dublin 1.025
Southend 818
Izmir 522
Princeton 492
Dearborn 421
Nanjing 421
Wilmington 346
Cambridge 257
Beijing 218
Ann Arbor 180
Ashburn 157
Nanchang 142
Boardman 138
Woodbridge 130
New York 116
Grevenbroich 99
Altamura 94
Singapore 83
Shenyang 71
Hebei 67
Tianjin 62
Houston 61
Chieti 58
Jiaxing 55
Kunming 51
Jinan 41
Norwalk 41
Hangzhou 39
Orange 39
Changsha 37
San Mateo 35
Augusta 32
Brno 30
Helsinki 29
Brussels 26
Dong Ket 26
Hefei 25
Grafing 24
Toronto 24
Guangzhou 22
Los Angeles 21
Washington 19
Andover 18
Ningbo 18
Auburn Hills 17
Chicago 17
Leawood 17
London 14
Ottawa 14
Lanzhou 13
Milan 13
Changchun 11
Taizhou 11
Zhengzhou 11
Falls Church 10
Düsseldorf 9
Rome 9
Mexico City 8
Seattle 8
Simi Valley 8
Lanciano 7
Vasto 6
Walnut 6
Frankfurt am Main 5
Fuzhou 5
Haikou 5
Sydney 5
Tappahannock 5
Baotou 4
Ferrara 4
Ardabil 3
Chongqing 3
Jülich 3
Kocaeli 3
Monmouth Junction 3
Mumbai 3
Redwood City 3
San Donà di Piave 3
Shanghai 3
Shaoxing 3
Trumbull 3
Arcene 2
Auckland 2
Bangalore 2
Bari 2
Cedar Knolls 2
Curtarolo 2
Desio 2
Harbin 2
Hong Kong 2
Layyah 2
Montesilvano Marina 2
Pescara 2
Porto San Giorgio 2
Qingdao 2
Quzhou 2
Redmond 2
Salerno 2
Totale 9.631
Nome #
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. 191
Tamoxifene e quercetina inibiscono la proliferazione di cellule neoplastiche polmonari "non small cell" in coltura e nei tumori primitivi. 169
Role of GM-CSF in cryptogenic organizing pneumonia 127
Apoptosi spontanea ed indotta da glicocorticoidi nei linfociti T periferici umani 113
Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung. 104
Ruolo della IL-1 nella regolazione della produzione del TGFbeta1 e della IL-8 nei tumori del polmone "non-small cell". 104
Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. 95
TGF-beta-1 and IL-8 in human long cancer cell lines and primary tumors: constitutive production and modulation by IL-1 95
T3 expression by human thymocytes in culture. 95
Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. 94
Transforming growth factor beta1, interleukin-8 and interleukin-1 in human non-small cell lung tumor cell lines and primary tumors. 94
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 89
Distribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness. 89
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 89
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 89
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 89
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 87
Growth inhibitory mechanism of quercetin and tamoxifen in human lung cancer cell lines 87
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 87
The mature, mitogen-responsive, human thymocyte population comprises two functionally distinct T-cell subsets differing in exogenous interleukin requirements for mitogenesis and in sensitivity to glucocorticoids. 87
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 87
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 85
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 85
Depletion of stromal and intraepithelial antigen-presenting cells in vervical neoplasia in human immunodificiency virus infection 84
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 83
Cellule immunocompetenti associate alla mucosa nella patologia della cervice uterina dei soggetti HIV-infetti 82
A solid phase radioimmunoassay for the diagnosis of human hydatidosis. 82
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 82
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 82
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 82
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 80
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 80
Carcinomi polmonari umani: produzione di TGFbeta1 79
Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients. 79
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 79
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 78
Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). 78
Proliferative capabilities of T3-positive thymocytes. 78
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 78
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 77
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 77
INTERACTION WITH TYPE II ESTROGEN BINDING SITES AND ANTIPROLIFERATIVE ACTIVITY OF TAMOXIFEN AND QUERCETIN IN HUMAN NON SMALL CELL LUNG CANCER. 77
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 77
IL-10 potentiates the effect of dexamethasone in inhibiting the proliferation of resting, activated and "corticoresistant" human T cells 77
Polymorphonuclear Leukocyte Apoptosis is Inhibited by Platelet-released mediators, Role of TGFbeta-1 76
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 76
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 76
Alpha-1-antitrypsin in umbilical cord serum: pi phenotypes and relationships with idiopathic respiratory distress syndrome. 76
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 75
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 75
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptors. 75
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 75
Analysis of IL-2-receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer. 74
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 74
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 74
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 74
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 73
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 73
Echinococcus granulosus: specific quantification of the two most immunoreactive antigens in hydatid fluids. 73
Alpha-l-antitrypsin deficiency and human pathology. 73
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 72
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 72
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 72
Neutrophils in anti-cancer immunological strategies: old players in new games 72
Alpha-1-antitrypsin phenotypes in newborns from Central and Southern Italy. 72
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 72
Inactivation of the IL-6 gene prevents development of multricentric Castleman's disease in C/EBP beta-deficient mice 71
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 71
WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome. 71
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 71
Glucocorticoid inhibitory action on OKT3 stimulated peripheral blood lymphocytes from renal transplant patients. 71
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 71
Growth inhibitory effect of quercetin and tamoxifen and presence of type II estrogen-binding sites in human lung cancer cell lines and primary tumors 70
Xenotransplantation rejection is antibody-mediated in both sensitized and nonsensitized recipients. 70
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 70
Immunological prevention of a multigene cancer syndrome. 69
THE ROLE OF ARACHIDONIC ACID METABOLITE PGE2 ON T CELL PROLIFERATIVE RESPONSE. 69
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 69
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 69
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 69
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 69
Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation. 69
IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation. 69
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 68
5-fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory 68
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 68
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 68
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 68
Echinococcus granulosus: preparation of monosepcific antisera against antigens in sheep hydatid fluid. 68
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 68
Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells. 68
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 67
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 67
Platelet-activating factor (PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferation 67
Neutrophils in the antitumoral immune response 67
T cell surface markers expression by immature human thymocytes in in vitro culture: role of Ia+ accessory cells. 67
T-cell nature of leukaemic cells in a case of Sézary's syndrome with 'null-cell' features. 67
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. 66
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. 66
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 66
Totale 7.958
Categoria #
all - tutte 51.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.172 0 239 1 177 183 323 416 351 34 123 298 27
2020/20211.618 261 5 246 9 221 340 10 6 135 253 44 88
2021/2022926 18 12 7 122 142 32 33 82 65 30 121 262
2022/20233.423 294 297 164 446 376 773 204 260 446 38 72 53
2023/20241.387 136 49 65 36 104 428 363 40 11 20 14 121
2024/2025247 224 23 0 0 0 0 0 0 0 0 0 0
Totale 15.672